Tempest Therapeutics, Inc.
TPST
$1.92
-$0.02-1.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.24% | -1.51% | -35.75% | -50.54% | -41.88% |
| Total Depreciation and Amortization | -31.62% | -41.18% | -32.45% | 7.27% | 2.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.81% | -24.73% | 3.88% | 26.34% | 53.81% |
| Change in Net Operating Assets | -418.04% | -278.44% | -117.79% | 280.93% | 160.25% |
| Cash from Operations | 18.79% | -14.95% | -45.11% | -29.10% | -20.73% |
| Capital Expenditure | -- | 99.32% | 95.75% | 8.56% | -155.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 99.32% | 95.75% | 8.56% | -155.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -46.11% | -292.22% | -- | -- | -- |
| Issuance of Common Stock | -74.48% | -41.50% | -26.51% | -16.89% | -18.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -82.62% | -54.90% | -49.28% | -35.21% | -31.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -151.74% | -231.12% | -223.90% | -214.13% | -210.98% |